Cholera pp 209-228 | Cite as

Pathophysiology and Clinical Aspects of Cholera

  • G. H. Rabbani
  • William B. GreenoughIII
Part of the Current Topics in Infectious Disease book series (CTID)

Abstract

Cholera may have been prevalent as an epidemic disease since antiquity (see Chapter 1), but only in the 1960s did research illuminate the mechanism of this disease. Before the discovery that a bacteria caused cholera, John Snow showed remarkable insight into the pathophysiology of the disease. For almost 80 years after Robert Koch’s isolation of Vibrio cholerae, the causative organism of epidemic cholera, however, a false idea of pathophysiology was propagated from teachings of Virchow.1 In 1959, SN De2 in India demonstrated that Vibrio cholerae produces a diarrheagenic toxin (cholera toxin). Over the next 30 years the toxin was fully characterized as were the mechanisms of toxin-induced diarrhea.3 In cholera patients, the origin and characteristics of diarrheal fluids were determined, the molecular basis of the action of cholera toxin (CT) was demonstrated, and its clinical consequences were established. Effective, low-cost therapeutic interventions were designed. This chapter will examine the progressive development of knowledge concerning the pathophysiologic and clinical aspects of cholera.

Keywords

Cholera Toxin Potassium Secretion Diarrheal Stool Mucus Coat Cholera Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Carpenter CCJ: Treatment of cholera—Tradition and authority versus science, reason, and humanity. Johns Hopkins Med J 139: 153–162, 1976.PubMedGoogle Scholar
  2. 2.
    De SN: Enterotoxicity of bacteria free culture filtrate of Vibrio cholerae? Nature 183: 1533, 1959.PubMedCrossRefGoogle Scholar
  3. 3.
    Rabbani GH: Cholera. Clin Gastroenterol 15: 507–528, 1986.PubMedGoogle Scholar
  4. 4.
    Baumann P, Furniss Al, Lee JV: Vibrio, in Kreig NR, Holt JG (eds): Bergey’s Manual of Systematic Bacteriology, Vol 1. Baltimore, Wiliams and Wilkins, 1984, pp 518–538.Google Scholar
  5. 5.
    Christie AB: Cholera, in Christie AB (ed): Infectious Diseases: Epidemiology and Clinical Practice. Churchill Livingston, Edinburgh, 1987, pp 193–230.Google Scholar
  6. 6.
    Hornick RB, Music SI, Wenzel R, et al: The Broad Street pump revisited: response of volunteers to ingested cholera vibrios. Bull NY Acad Med 47: 1181–1191, 1971.Google Scholar
  7. 7.
    Cahs R, Music S, Libonate J, et al: Response of man to infection with V. cholerae. 1. Clinical, serologic, and bacteriologic response to a known inoculum? J Infect Dis 129: 45, 1974.CrossRefGoogle Scholar
  8. 8.
    Carpenter CCJ: Pathogenesis and pathophysiology of cholera? Pub Hlth Pap 40: 53, 1970.Google Scholar
  9. 9.
    Gitelson S: Gastrectomy, achlorhydria and cholera. Israel J Med Sci 7: 633–637, 1971.Google Scholar
  10. 10.
    Bain WB, Zampieri A, Mazzotti M, et al: Epidemilogy of cholera in Italy in 1973. Lancet ii: 1370–1374, 1974.CrossRefGoogle Scholar
  11. 11.
    Gilman RH, Partanen R, Brown KH, Spira WM, Khanam S, Greenberg B, Bloom SR, Ali A: Decreased gastric acid secretion and bacterial colonization of the stomach in severely malnourished Bangladeshi children. Gastroenterol 94: 1308–1314, 1988.Google Scholar
  12. 12.
    Jones GW, Freter R: Adhesive properties of Vibrio cholerae: nature of the interaction with isolated rabbit brush border membranes and human erythrocytes. Infect Immun 14: 240–245, 1976.PubMedGoogle Scholar
  13. 13.
    Boedeker EC: Enterocyte adherence of Escherichia coli: its relation to diarrheal disease. Gastroenterol 83: 489–492, 1982.Google Scholar
  14. 14.
    Walker WA, Wu M, Isselbacher KJ, Block KJ: Intestinal uptake of macromolecules. IV. The effect of pancreatic duct ligation on the breakdown of antigen and antigen-antibody complexes on the intestinal surface. Gastroenterol 69: 1223–1229, 1975.Google Scholar
  15. 15.
    Evans DG, Silver RP, Evans DJ Jr, Chase DG, Gorbach SL: Plasmid controlled colonization factor associated with virulence in Escherichia coli enterotoxigenic for humans. Infect Immun 12: 656–667, 1975.PubMedGoogle Scholar
  16. 16.
    Holt SC: Bacterial adhesion in pathogenesis: an introductory statement, in: Schlessinger D (ed.): Microbiology, 1982. Washington DC, American Society for Microbiology, 1982, pp 261–265.Google Scholar
  17. 17.
    Teppema JS, Guinee PAM, Ibrahim AA, Paques M, Ruitenberg EJ: In vivo adherence and colonization of Vibrio cholerae strains that differ in hemagglutinating activity and motility. Infect Immun 55: 2093–2102, 1987.PubMedGoogle Scholar
  18. 18.
    Taylor RK, Miller VL, Furlong DB, Mekalanos JJ: Use of phoA gene fusion to identify a pilus colonization factor coordinately regulated with cholera toxin. Proc Natl Acad Sci USA 84: 2833–2837, 1987.PubMedCrossRefGoogle Scholar
  19. 19.
    Herrington DA, Hall RA, Losnosky G, Mekalanos JJ, Taylor RK, Levine MM: Toxin, toxin-coregulated pili, and the toxR regulation are essential for Vibrio cholerae pathogenesis in human. J Exp Med 168: 1487–1492, 1988.PubMedCrossRefGoogle Scholar
  20. 20.
    Yamamoto T, Takeshi Y: Electron microscopic study of Vibrio cholerae 01 adherence to the mucus coat and villous surface in the human small intestine. Infect Immun 56: 2753–2759, 1988.PubMedGoogle Scholar
  21. 21.
    Bresson JL, Pang KY, Walker WA: Microvillous membrane differentiations: quantitative difference in cholera toxin binding to the intestinal surface of new born and adult rabbits. Paediatr Research 18: 984–987, 1984.Google Scholar
  22. 22.
    Davidson JN, Hirschhorn DC: Use of the K88 antigen for in vivo bacterial competition with porcine strains of enteropathogenic Escherchia coli. Infect Immun 12: 134–136, 1975.PubMedGoogle Scholar
  23. 23.
    Finkelstein RA, Boesman-Finkelstein M, Holt P: Vibrio cholerae hemagglutination (lectin) protease hydrolyses fibronectin and ovomucin. Proc Natl Acd Sci USA 80: 1092–1095, 1983.CrossRefGoogle Scholar
  24. 24.
    Wald A, Gotterer, GS, Rajendra GR, Turjjman NA, Hendrix TR: Effect of indomethacin on cholera-induced fluid movement, unidirectional sodium fluxes, and intestinal cAMP. Gastroenterol 72: 106–110, 1977.Google Scholar
  25. 25.
    Jacoby HI, Marshall CH: Antagonism of cholera enterotoxin by antiinflammatory agents in the rat. Nature 235: 163–165, 1972.PubMedCrossRefGoogle Scholar
  26. 26.
    Speelman P, Rabbani GH, Bukhave K, Rask-Madesn K: Increased jejunal prostaglandin E2 concentrations in patients with acute cholera. Gut 26: 188–193, 1985.PubMedCrossRefGoogle Scholar
  27. 27.
    Pierce NF, Greenough WB III, Carpenter CCJ: Vibrio cholerae enterotoxin and its mode of action. Bactreriol Rev 35: 1–12, 1971.Google Scholar
  28. 28.
    Gangarosa EJ, Beisel WR, Benyajati C, et al: The nature of the gastrointestinal lesion in Asiatic cholera and its relation to pathogenesis: A biopsy study. Am J Trop Med 9: 125–135, 1960.Google Scholar
  29. 29.
    Greenough WB III: Pancreatic and hepatic hypersecretion in cholera. Lancet ii: 991–993, 1965.CrossRefGoogle Scholar
  30. 30.
    Banwell JG, Pierce NF, Mitra RC, Brigham KL, Caranasos GJ, Keimowitz RI, Fedson DS, Thomas J, Gorbach SL, Sack RB, Mondai A: Intestinal fluid and electrolyte transport in human cholera. J Clin Invest 49: 183–195, 1970.PubMedCrossRefGoogle Scholar
  31. 31.
    Pierce NF, Sack RB, Mitra RC, Banwell JG, Brigham KL, Fedson DS, Mondai A: Replacement of water and electrolyte losses in cholera by an oral glucose electrolyte solution. Ann Int Med 70: 1173–1181, 1969.PubMedCrossRefGoogle Scholar
  32. 32.
    Carpenter CCJ, Sack RB, Feeley JC, Steenberg RW: Site and characteristics of electrolyte loss and effect of intraluminal glucose in experimental canine cholera. J Clin Invest 47: 1210–1220, 1968.PubMedCrossRefGoogle Scholar
  33. 33.
    Carpenter CCJ, Greenough WB III: Response of canine duodenum to intraluminal challenge with cholera toxin. J Clin Invest 47: 2600–2608, 1968.PubMedCrossRefGoogle Scholar
  34. 34.
    Carpenter CCJ, Mondai A, Sack RB, Mitra PP, Dans PE, Wells SA, Hinman EJ, Chaudhury RN: Clinical studies in Asiatic cholera. Bull Johns Hopkins Hosp 118: 174–196, 1966.Google Scholar
  35. 35.
    Watten RH, Morgan RM, Songkhla YN, Vanikiati V, Phillips RA: Water and electrolyte studies in cholera. J Clin Invest 38: 1879–1889, 1959.PubMedCrossRefGoogle Scholar
  36. 36.
    Greenough WB III, Rosenberg IS, Gordon RS, Davies BI: Tetracycline in the treatment of cholera. Lancet 1: 355–357, 1964.PubMedCrossRefGoogle Scholar
  37. 37.
    Batt ER, Schacter D: Developmental pattern of some intestinal transport mechanisms in new born rats and mice. Am J Physiol 261: 1064–1068, 1969.Google Scholar
  38. 38.
    Binder HJ: Amino acid absorption from the mammalian colon. Biochem Biophys Acta 219: 503–506, 1970.PubMedCrossRefGoogle Scholar
  39. 39.
    Debongnie JC, Phillips SF: Capacity of the human colon to absorb fluid. Gastroenterol 74: 698–703, 1978.Google Scholar
  40. 40.
    Phillips SF, Giller J: The contribution of colon to electrolytes and water conservation in man. J Lab Clin Med 81: 733–746, 1973.PubMedGoogle Scholar
  41. 41.
    Read NW: Diarrhea: the failure of colonic salvage. Lancet ii: 481–483, 1982.CrossRefGoogle Scholar
  42. 42.
    Speelman P, Butler T, Kabir I, Ali A, Banwell J: Colonie dysfunction during cholera infection. Gastroenterol 91: 1164–1170, 1986.Google Scholar
  43. 43.
    Sack RB, Carpenter CCJ, Steenberg RW, Pierce NF: Experimental cholera: a canine model. Lancet ii: 206–207, 1966.CrossRefGoogle Scholar
  44. 44.
    Swab EA, Hynes ZA, Donowitz M: Elevated intramural pressure alters rabbit small intestinal transport in vivo. Am J Physiol 242:G58–G64, 1982.Google Scholar
  45. 45.
    Donowitz M, Binder HJ: Effect of enterotoxins of Vibrio cholerae, Escherichia coli, and Shigella dysentariae type 1 on fluid and electrolyte transport in the colon. J Infect Dis 134: 135–143, 1976.PubMedCrossRefGoogle Scholar
  46. 46.
    Schultz SG: Sodium and chloride absorption by small and large intestine: an overview, in: Janowitz HD, Sachar DB (eds): Frontiers of Knowledge in the Diarrheal Diseases. Upper Montclair, NJ, Projects in Health, Inc, 1979.Google Scholar
  47. 47.
    Schultz SG, Frizzel RA, Nellans HN: Sodium transport and the electrophysiology of rabbit colon. J Membr Biol 33: 351–384, 1977.PubMedCrossRefGoogle Scholar
  48. 48.
    Frizzel RA, Schultz SG: Effects of aldosterone on ion transport by rabbit colon in vitro. J Membr Biol 39: 1–26, 1978.CrossRefGoogle Scholar
  49. 49.
    Phillips SF, Schmalz PF: Bicarbonate secretion by the rat colon: effect of intraluminal chloride and acetazolamide. Proc Soc Exp Biol Med 135: 116–122, 1970.PubMedCrossRefGoogle Scholar
  50. 50.
    Field M: Intestinal secretion. Gastroenterol 66: 1063–1084, 1974.Google Scholar
  51. 51.
    Love AHG, Phillips RA, Rhode JE, Veall N: Sodium ion movement across intestinal mucosa in cholera patients. Lancet ii: 151–153, 1972.CrossRefGoogle Scholar
  52. 52.
    Foster ES, Sandle GI, Hayslett JP, Binder HJ: Cyclic adenosine monophosphate stimulates active potassium secretion in the rat colon. Gastroenterol 84: 324–330, 1983.Google Scholar
  53. 53.
    Johnson J, Casper AGT, Carpenter CCJ: Effects of desoxycorticosterone on potassium concentration in enterotoxin-stimulated small intestinal secretions. Johns Hopkins Med J 133: 201–206, 1973.PubMedGoogle Scholar
  54. 54.
    Carpenter CCJ, Mondai A, Sack RB, et al: Clinical studies in Asiatic cholera. II. Development of 2: 1 saline lactate regimen. Johns Hopkins Med J 118: 174–196, 1966.Google Scholar
  55. 55.
    Levitn R, Ingelfinger FI: Effect of d-aldosterone on salt and water absorption from the intact human colon. J Clin Invest 44: 801–808, 1965.CrossRefGoogle Scholar
  56. 56.
    Argenzio RA: Short chain fatty acids and the colon. Dig Dis Sci 26: 97–99, 1981.PubMedCrossRefGoogle Scholar
  57. 57.
    Oseasohn R, Ahmad S, Islam MA, Rahaman ASMM: Clinical and bacteriological findings among families of cholera patients. Lancet i: 340–342, 1966.CrossRefGoogle Scholar
  58. 58.
    Bart KJ, Huq Z, Khan M, Mosley WH: Seroepidemiologic studies during a simultaneous epidemic of infection with El Tor Ogawa and classical Inaba Vibrio cholerae. J Infect Dis 121(suppl.):S17–S24, 1970.CrossRefGoogle Scholar
  59. 59.
    Lindenbaum J, Greenough WB III, Islam MR: Antibiotic therapy of cholera. Bull WHO 36: 871–833, 1967.PubMedGoogle Scholar
  60. 60.
    Carpenter CCJ, Barua D, Wallace CK, Mitra P, Sack RB, Khanra SR, Wells SA, Dans PE, Chaudhury RN: Clinical studies in Asiatic cholera. IV. Antibiotic therapy in cholera. Bull Johns Hopkins Hosp 118: 216–229, 1966.Google Scholar
  61. 61.
    Hirschhorn N, Kinzie JL, Sachar DB, Northrup RS, Taylor JO, Ahmed SZ, Phillips RA: Decrease in net stool output in children during intestinal perfusion with glucose-containing solutions. N Eng J Med 279: 176–181, 1968.CrossRefGoogle Scholar
  62. 62.
    Pierce NF, Banwell JG, Mitra RC, Caranasos GJ, Keimowitz RI, Thomas J, Mondai A: A controlled comparison of tetracycline and furazolidone in cholera. Brit Med J 3: 277–280, 1968.PubMedCrossRefGoogle Scholar
  63. 63.
    Wang F, Butler T, Rabbani GH, Jones PK: The acidosis of cholera: contributions of hyperproteinemia, lactic acidemia, and hyperphosphatemia to an increased serum anion gap. N Eng J Med 315: 1591–1595, 1986.CrossRefGoogle Scholar
  64. 64.
    Mahalanabis D, Wallace CK, Kallen RJ, Mondai A, Pierce NF: Water and electrolyte losses due to cholera in infants and small children: A recovery balance study. Pediatrics 45: 374–385, 1970.PubMedGoogle Scholar
  65. 65.
    Greenough WB III, Hirschhorn N, Gordon RS Jr, Linderbaum J, Ally KM: Pulmonary edema associated with acidosis in patients with cholera. Trop Geogr Med 28: 86–90, 1976.PubMedGoogle Scholar
  66. 66.
    Benyajati C, Keoplug M, Beisel WR, Gangarosa EJ, Sprinz H, Sitprija V: Acute renal failure in Asiatic cholera: clinicopathologic correlations with acute tubular necrosis and hypokalemic nephropathy. Ann Int Med 52: 960–975, 1960.PubMedCrossRefGoogle Scholar
  67. 67.
    Carpenter CCJ, Mitra RP, Sack RB: Clinical studies in Asiatic cholera. I. Preliminary observations, November, 1962–March, 1963. Bull Johns Hopkins Hosp 118: 165–173, 1966.Google Scholar
  68. 68.
    Knochel JP: Biochemical, electrolyte, and acid-base disturbance in acute renal failure, in, Brenner BM, Lazarus JM (eds): Acute Renal Failure. Philadelphia, WB Saunders, 1983, pp 568–585.Google Scholar
  69. 69.
    Molla AM, Hossain M, Islam R, Bardhan PK, Sarkar SA: Hypoglycemia: a complication of diarrhea in childhood. Indian Pediatr 18: 181–185, 1981.PubMedGoogle Scholar
  70. 70.
    Jones RG: Hypoglycemia in children with acute diarrhea. Lancet ii:643, 1966.CrossRefGoogle Scholar
  71. 71.
    Hirschhorn N, Lindenbaum J, Greenough III WB, Alam SM: Hypoglycemia in children with acute diarrhea. Lancet ii: 128–132, 1966.CrossRefGoogle Scholar
  72. 72.
    Bennish ML, Azad Ak, Rahman O, Phillips RE: Hypoglycemia during diarrhea in childhood: Prevalence, pathophysiology, and outcome. N Eng J Med 322: 1357–1363, 1990.CrossRefGoogle Scholar
  73. 73.
    Senior B, Sadeghi-Nejad A: Hypoglycemia: a pathophysiologic approach. Acta Ped Scand (suppl)352, 1989.Google Scholar
  74. 74.
    McCallum RE, Seale TW, Stith RD: Influence of endotoxin treatment on dexamethasone induction of hepatic phosphoenolpyruvate carboxylase. Infect Immun 39: 213–239, 1983.PubMedGoogle Scholar
  75. 75.
    Knowles RG, McCabe JP, Beevers SJ, Pogson CI: The characteristics and sign of inhibition of gluconeogenesis in rat liver cells by bacterial endotoxin. Biochem J 242: 721–728, 1987.PubMedGoogle Scholar
  76. 76.
    Carpenter CCJ, Biern RO, Mitra PP, Sack RB, Dans PE, Wells SA, Khanra SS: Electrocardiogram in Asiatic cholera. Seperated studies of effects of hypovolemia, acidosis, and potassium loss. Brit Heart J 29: 103–111, 1967.PubMedCrossRefGoogle Scholar
  77. 77.
    Ally KM, Greenough WB III: Electrocardiographic changes during shock due to cholera and other causes. East Pakistan Med J 10: 1–8, 1966.Google Scholar
  78. 78.
    Mahalanabis D, Brayton JB, Mondai A, Pierce NF: The use of Ringer’s lactate in the treatment of children with cholera and acute noncholera diarrhea. Bull WHO 46: 311–319, 1972.PubMedGoogle Scholar
  79. 79.
    Hirschhorn N, Chaudhury AKMA, Lindenbaum J: Cholera in pregnant women. Lancet i: 1230–1232, 1969.CrossRefGoogle Scholar
  80. 80.
    Harvey RM, Enson Y, Lewis ML, Greenough III WB, Ally KM, Panno RA: Hemodynamic studies on cholera. Effect of hypovolemia and acidosis. Circulation 37: 709–728, 1968.PubMedCrossRefGoogle Scholar
  81. 81.
    Pierce NF, Mondai A: Clinical features of cholera, in Barua D, Burrows W (eds): Cholera. Philadelphia, WB Saunders, 1974, p 216.Google Scholar
  82. 82.
    Pierce NF, Graybill JR, Kaplan MM, Bauwman DL: Systemic effects of parenteral cholera enterotoxin in dogs. J Lab Clin Med 79: 145–156, 1972.PubMedGoogle Scholar
  83. 83.
    Iwert ME, Deb BD, Srivastava DL, Burrows W: Cholera toxins: Increased levels of serum glutamic-oxalloacetic transaminase in human cholera. J Infect Dis 118: 422–426, 1968.PubMedCrossRefGoogle Scholar
  84. 84.
    Mosley WH, Benenson AS, Barui KR: A serological survey of cholera antobodies in rural East Pakistan. 1. The distribution of area and the relation of antibody titer to the pattern of endemic cholera. Bull WHO 38: 327–334, 1968.PubMedGoogle Scholar
  85. 85.
    Cohen MB, Moyer S, Lutterell M, Gianella RA: The immature rat small intestine exhibits an increased sensitivity and response to Escherichia coli heat-stable enterotoxin. Pediatr Res 20: 555–560, 1986.PubMedCrossRefGoogle Scholar
  86. 86.
    Griffith LSC, Fresh JW, Watten RH, Willaroman MP: Electrolyte replacement in pediatric cholera. Lancet i: 1197–1199, 1967.CrossRefGoogle Scholar
  87. 87.
    Rabbani GH, Islam MR, Butler T, Shahriar M, Alam K: Single-dose treatment of cholera with furazolidone or tetracycline in a double-blind randomized trial. Antimicrob Agents Chemother 33: 1447–1450, 1989.PubMedCrossRefGoogle Scholar
  88. 88.
    Rabbani GH, Greenough III WB, Holmgren J, Kirkwood B: Controlled trial of chlorpromazine as antisecretory agent in patients with cholera hydrated intravenously. Brit Med J 284: 1361–1364, 1982.CrossRefGoogle Scholar
  89. 89.
    Koch SW, Metcoff J: Physiologic considerations in fluid and electrolyte therapy with particular reference to diarrheal dehydration in children. J Pediatr 62: 107–131, 1963.CrossRefGoogle Scholar
  90. 90.
    Beisel WR, Watten RH, Blackwell RQ, Benyajati C, Phillips RA: The role of bicarbonate pathophysiology and therapy in Asiatic cholera. Am J Med 35: 58–66, 1963.PubMedCrossRefGoogle Scholar
  91. 91.
    Friis-Hansen B: Body water compartments in children: changes during growth and related changes in the body composition. Pediatr 28: 169–181, 1961.Google Scholar
  92. 92.
    Cheek DB: Extracellular volume, its structure and measurement and the influence of age and disease. J Pediatr 58: 103–125, 1961.PubMedCrossRefGoogle Scholar
  93. 93.
    Carpenter CCJ: Clinical and pathophysiologic features of diarrhea caused by Vibrio cholerae and Escherichia coli, in Field M, Fordtran JS, Schultz SG (eds): Secretory Diarrhea. Bethesda, MD, American Physiological Society, 1980, pp 67–83.Google Scholar
  94. 94.
    Scrimshaw NS, Taylor CE, Gordon JE: Interactions of nutrition and infection. World Health Organization Monograph Series no. 57. Geneva World Health Organization, 1968.Google Scholar
  95. 95.
    Rowland MG, Cole TJ, Whitehead RG: A quantitative study into the role of infection in determining nutritional status in Gambian village children. Brit J Nutr 37: 441–450, 1977.PubMedCrossRefGoogle Scholar
  96. 96.
    Hoyle B, Yunus M, Chen LC: Breast feeding and food intake among children with acute diarrheal disease. Am J Clin Nutr 33: 2365–2367, 1980.PubMedGoogle Scholar
  97. 97.
    Molla AM, Molla A, Sarker SA, Rahaman MM: Food intake during and after recovery from diarrhea in children, in Chen LC, Scrimshaw S (eds): Diarrhea and Malnutrition. New York, Plenum Press, 1983, pp 113–123.CrossRefGoogle Scholar
  98. 98.
    Molla AM, Molla A, Khatun M: Does oral rehydration therapy alter food consumption and absorption of nutrients in children with cholera. J Trop Med Hyg 89: 113–117, 1986.PubMedGoogle Scholar
  99. 99.
    Martorell R, Yarbrough C, Yarbrough S, Klein RE: The impact of ordinary illness on the dietary intakes of malnourished children. Am J Clin Nutr 33: 345–357, 1980.PubMedGoogle Scholar
  100. 100.
    Hirschhorn N, Molla A: Reversible jejunal disaccharidase deficiency in cholera and other acute diarrheal diseases. Johns Hopkins Med J 125: 291–293, 1969.PubMedGoogle Scholar
  101. 101.
    Mahalanabis D, Watten R, Wallace CK: Clinical aspects and management of pediatric cholera, in: Barua D, Burrows W (eds): Cholera. Philadelphia, WB Saunders, 1974, pp 223–227.Google Scholar
  102. 102.
    Molla AM: Cholera, in: Rakel ED (ed): Conn’s Current Therapy, Philadelphia, WB Saunders, 1989, pp. 48–51.Google Scholar

Copyright information

© Springer Science+Business Media New York 1992

Authors and Affiliations

  • G. H. Rabbani
  • William B. GreenoughIII

There are no affiliations available

Personalised recommendations